英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
stringens查看　stringens　在百度字典中的解释百度英翻中〔查看〕
stringens查看　stringens　在Google字典中的解释Google英翻中〔查看〕
stringens查看　stringens　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Fruzaqla: Uses, Dosage, Side Effects, Warnings - Drugs. com
    Males with female partners who can become pregnant should use effective birth control during treatment with Fruzaqla and for 2 weeks after their last dose Tell your healthcare provider right away if your partner becomes pregnant during your treatment It is not known if Fruzaqla passes into your breast milk
  • FDA approves fruquintinib in refractory metastatic colorectal cancer
    On November 8, 2023, the Food and Drug Administration approved fruquintinib (Fruzaqla, Takeda Pharmaceuticals, Inc ) for adult patients with metastatic colorectal cancer (mCRC) who received prior
  • News from the FDA–new treatments for metastatic colorectal cancer
    New Drug Approvals Fruzaqla The FDA approved a new cancer treatment option for metastatic colorectal cancer Fruzaqla (fruquintinib), a targeted therapy known as an anti-VEGF treatment, works by blocking the blood supply to a tumor Fruzaqla is approved for adults with metastatic colorectal cancer (mCRC) who were previously treated with chemotherapy and a different anti-VEGF therapy
  • FRUZAQLA® (fruquintinib) for Previously Treated mCRC
    For adults with metastatic colorectal cancer (mCRC), FRUZAQLA is an innovative and convenient oral treatment with proven survival results that can be taken after chemotherapy and other anti-cancer medications FRUZAQLA is a targeted therapy for people living with previously treated mCRC FRUZAQLA is not chemotherapy
  • Fruquintinib (Fruzaqla®) for Colon Cancer | ChemoExperts
    Hospice services focus on quality of life and symptom management so typically, some preventative therapies and long-term medications are stopped Certain anti-cancer treatment may be stopped, but if the anti-cancer medication is helping to prevent side effects and discomfort they may be continued in some instances
  • Fruzaqla (Fruquintinib Capsules): Side Effects, Uses, Dosage . . . - RxList
    Fruzaqla (fruquintinib) is a kinase inhibitor indicated for the treatment of adult patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if RAS wild-type and medically appropriate, an anti-EGFR therapy
  • Fruzaqla Approval Has ‘Impressive’ Survival Benefit in . . . - Curetoday
    Qand quality of life was maintained in about 65% of patients in both arms, placebo and in the Fruzaqla arm, which is pretty good And I think that this is a very exciting drug, a new option for patients with metastatic colon cancer, who have progressed on all the standard-of-care therapies,” noted Dr Monga
  • Getting Immunotherapy Treatment | OPDIVO® (nivolumab)
    Learn more about receiving OPDIVO® (nivolumab) or OPDIVO-based combination treatment Access infusion information for your cancer type Please see Indication and Important Safety Information
  • NICE turns down Takeda colorectal cancer drug | pharmaphorum
    The ongoing review covers the use of Fruzaqla to treat metastatic colorectal cancer in patients who previously received chemotherapy, with or without anti-VEGF drugs, and anti-EGFR treatment if
  • New colorectal cancer treatment approved in the U. S. - Takeda
    OSAKA, Japan and CAMBRIDGE, Massachusetts, November 8, 2023 – Takeda (TSE:4502 NYSE:TAK) today announced that the U S Food and Drug Administration (FDA) has approved FRUZAQLA™ (fruquintinib), an oral targeted therapy for adults with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine-, oxaliplatin





中文字典-英文字典  2005-2009